ArticleProbiotics and antimicrobial proteins2026
Lactiplantibacillus plantarum Strains LP5 and BX62 Alleviate Liver Injury of NAFLD in Rats via Regulating Hepatic Cholesterol Metabolism and Antioxidant Signaling Pathways.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Disorders of lipid metabolism and oxidative stress are pivotal factors in the advancement of non-alcoholic fatty liver disease (NAFLD). This study aims to investigate the liver-protective effects of two Lactiplantibacillus plantarum (L. plantarum) strains, LP5 and BX62, either individually or in combined, on NAFLD in rats induced by high fat and cholesterol diet. Strain L. plantarum LP5 showed potential for modulating cholesterol metabolism, whereas L. plantarum BX62 exhibited enhanced antioxidant properties. All three intervention strategies alleviated liver injury, as evidenced by reduced hepatic lipid accumulation, intestinal permeability, inflammation, and liver injury markers. Notably, L. plantarum LP5 showed greater effects on reducing weight gain and hepatic steatosis, while L. plantarum BX62 provided additional protection against hepatic oxidative damage. Metabolic and molecular analyses suggested that the beneficial effects of L. plantarum LP5 were associated with altered bile acid homeostasis and increased expression of hepatic primary bile acid synthesis-related proteins (CYP7A1 and CYP8B1), whereas L. plantarum BX62 was associated with activation of the Nrf2-HO-1 antioxidant pathway (Nrf2, HO-1, and FTH). Furthermore, all intervention strategies activated AMPK signaling (p-AMPK/AMPK), accompanied by decreased expression of lipogenesis-related proteins (SREBP-1c, FASN, and SCD1) and increased expression of fatty acid oxidation-related proteins (PPARα and CPT1a), contributing to improved hepatic lipid metabolism. Collectively, our findings indicate that L. plantarum LP5 and L. plantarum BX62 alleviate HFHC diet-induced hepatic metabolic disturbances by complementary mechanisms involving cholesterol metabolism and antioxidant responses, highlighting their potential as dietary probiotics for supporting liver health and preventing NAFLD progression.
Indexed as
Identifiers
42895609What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.